These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31358444)

  • 1. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
    Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Porcu P; Martinez NL; Glass J; Mashayekhi A; Shields CL
    Asia Pac J Ophthalmol (Phila); 2020; 9(2):110-116. PubMed ID: 31923035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreoretinal large B- cell lymphoma (VR- LBCL): Clinical and pathological features and treatment outcomes.
    Fadlelseed H; Rhatigan M; Treacy M; Murphy C; O'Neill J; Kilmartin D; Kennedy S
    Pathol Res Pract; 2024 Sep; 261():155500. PubMed ID: 39106590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
    Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
    JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreoretinal Lymphoma with Intraretinal Infiltration, Simulating Retinal Necrosis.
    Guan WX; Peng XY
    Ophthalmol Retina; 2024 Jun; 8(6):571-578. PubMed ID: 38040056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors related to central nervous system involvement of primary vitreoretinal lymphoma.
    Kim JY; Kim JJ; Kim RY; Kim M; Park YG; Park YH
    Graefes Arch Clin Exp Ophthalmol; 2024 Aug; 262(8):2421-2429. PubMed ID: 38446203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
    Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
    Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
    Klimova A; Heissigerova J; Rihova E; Brichova M; Pytlik R; Spicka I; Mrazova K; Karolova J; Svozilkova P
    Br J Ophthalmol; 2018 Nov; 102(11):1579-1585. PubMed ID: 29378728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual case report of primary vitreoretinal lymphoma.
    Tan SZ; Steeples LR; Chhabra R; Jones NP
    BMC Ophthalmol; 2018 Sep; 18(Suppl 1):223. PubMed ID: 30255824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
    Cho BJ; Kim DY; Park UC; Lee JY; Yoon YH; Yu HG
    Ocul Immunol Inflamm; 2018; 26(3):365-371. PubMed ID: 29394118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
    Liu S; Gu J; Zhang T; Ping B; Zhou M; Huang X; Jiang R; Xu G; Chang Q
    Retina; 2021 Dec; 41(12):2596-2604. PubMed ID: 34173362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Silent Masquerade: Clinical and Imaging Features of Asymptomatic Vitreoretinal Lymphoma.
    Menean M; Cicinelli MV; Rivolta MC; Marchese A; Modorati G; Bandello F; Miserocchi E
    Am J Ophthalmol; 2024 Nov; 267():153-159. PubMed ID: 38977150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma.
    Guan W; Xiao Y; Zhao H; Hu F; Chen C; Peng X
    Clin Exp Ophthalmol; 2023 Mar; 51(2):144-153. PubMed ID: 36567492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES OF VITREORETINAL LYMPHOMA IN 55 EYES.
    Yang X; Dalvin LA; Mazloumi M; Ferenczy S; Lim LS; Ancona-Lezama D; Shields JA; Mashayekhi A; Shields CL
    Retina; 2021 Feb; 41(2):249-258. PubMed ID: 32349103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
    Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
    Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitreoretinal lymphoma: Central nervous system lymphoma risk with unilateral or bilateral ocular tumour. A multicentre collaboration.
    Dalvin LA; Pulido JS; Shields CL; Marchese A; Miserocchi E; Frenkel S; Pe'er J
    Eye (Lond); 2023 Jan; 37(1):54-61. PubMed ID: 34999721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive overview of diagnosis, imaging and treatment of vitreoretinal lymphoma.
    Menean M; Giuffrè C; Cicinelli MV; Marchese A; Modorati G; Bandello F; Miserocchi E
    Eur J Ophthalmol; 2024 Jul; 34(4):931-940. PubMed ID: 37956540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical coherence tomography features in vitreoretinal lymphoma compared with non-infectious uveitis.
    El Zein L; Smith WM; White LJ; Hodge DO; Olsen TW; Pulido JS; Dalvin LA
    BMC Ophthalmol; 2024 Jun; 24(1):255. PubMed ID: 38872120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution.
    Turaka K; Bryan JS; De Souza S; Gordon AJ; Kwong HM; Ziemianski MC; Reddy R; Sell CH
    Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):412-7. PubMed ID: 22995952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.